1q21.1 duplication syndrome
A genetic disorder caused by duplication of a region on chromosome 1
1q21.1 duplication syndrome is a genetic disorder caused by the duplication of a small region on the long arm of chromosome 1. This condition is associated with a variety of clinical features, which can vary widely among affected individuals.
Genetics[edit | edit source]
1q21.1 duplication syndrome is characterized by the presence of an extra copy of a segment of genetic material on chromosome 1, specifically at the 1q21.1 location. This duplication can be inherited in an autosomal dominant manner, meaning that a single copy of the duplicated region is sufficient to cause the disorder. However, the condition can also occur de novo, meaning it arises spontaneously without being inherited from a parent.
Clinical Features[edit | edit source]
The clinical presentation of 1q21.1 duplication syndrome is highly variable. Some individuals with the duplication may be asymptomatic, while others may exhibit a range of symptoms. Common features include:
- Developmental delay
- Intellectual disability
- Autism spectrum disorder
- Congenital heart defects
- Microcephaly or macrocephaly
- Seizures
Diagnosis[edit | edit source]
Diagnosis of 1q21.1 duplication syndrome is typically made using genetic testing methods such as chromosomal microarray analysis or fluorescence in situ hybridization (FISH). These tests can identify the presence of the duplicated region on chromosome 1.
Management[edit | edit source]
There is no cure for 1q21.1 duplication syndrome, and treatment is generally supportive and symptomatic. Management may involve:
- Early intervention programs for developmental delays
- Special education services
- Speech therapy, occupational therapy, and physical therapy
- Medical management of associated conditions such as seizures or heart defects
Prognosis[edit | edit source]
The prognosis for individuals with 1q21.1 duplication syndrome varies depending on the severity of symptoms and associated conditions. Some individuals may lead relatively normal lives, while others may require ongoing medical and educational support.
Related pages[edit | edit source]
Gallery[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD